Adaptive Biotechnologies is a commercial-stage biotechnology company focused on leveraging the adaptive immune system for disease diagnosis and treatment. They offer an immune-sequencing platform and develop products used by healthcare providers across multiple medical fields. Adaptive partners with organizations like Microsoft and pharmaceutical companies to develop diagnostics and research projects, including COVID-19 vaccines and cancer cell therapies. Their work involves analyzing T cells and their receptors to understand immune responses to various conditions.
All verified mentions of this organization in source documents.
No mentions found for this organization.